Staburo
Staburo is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
A prospective, randomised, multi-centre, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges with benzydamine hydrochloride and dichlorobenzyl alcohol in the symptomatic treatment of patients suffering from acute pharyngitis
Sponsor MEDICE Arzneimittel Puetter GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
A prospective multi-centric, randomised, double-dummy, double- blind, placebo-controlled 3-way Phase III study to investigate the efficacy and safety of two dexamfetamine sulfate formulations in adults with ADHD - DEXINA -
Sponsor Medice Arzneimittel Puetter GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
- Not reported
A prospective, randomized, evaluator- and subject blinded, multi-center investigation to assess efficacy and safety of three different dosages of the same injection pattern of LetibotulinumtoxinA in the treatment of moderate and severe horizontal forehead lines
Sponsor Croma-Pharma GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Adaptive Phase 3 Study to Evaluate the Efficacy and Safety of Sinecatechins (Defined Extract of Green Tea Leaves) Ointment in Adult Patients with Actinic Keratosis of the Scalp and the Face.
Sponsor Aresus Pharma GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressive patients with multiple myeloma after a first-line therapy
Sponsor University Medical Center Hamburg-Eppendorf
- Start (EU)
- Latest update
- Estimated end
- Not reported
A prospective, multi-centre, randomised, double-blind, placebo-controlled Phase III trial to investigate the efficacy and safety of lozenges with benzydamine hydrochloride and dichlorobenzyl alcohol in the symptomatic treatment of patients suffering from acute pharyngitis
Sponsor MEDICE Arzneimittel Puetter GmbH & Co. KG
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihistamines
Sponsor Jasper Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A placebo controlled, randomized, double-blind, dose titration phase 2, safety and efficacy study of ORE-001 (oral lidocaine) in underweight elderly participants
Sponsor Orexa B.V.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Staburo?
The 2026-10-09 snapshot links Staburo to 8 distinct CTIS trials. Recorded services include Statistical analysis, Randomization, Data management, Medical writing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Staburo?
The most frequently recorded therapeutic areas are Infectious Disease, Otolaryngology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Staburo conducted?
The linked trials record locations in 3 countries, including Germany, Austria, Netherlands. These are trial locations, not confirmed office locations or countries where Staburo delivered services.
What can this page tell me about Staburo's trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Staburo. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Staburo GmbH